Axsome Therapeutics to Attend Four Investor Conferences
Axsome Therapeutics will participate in four investor conferences.
Related stories
Utkarsh Small Finance Bank Reports Q2 Net Loss of 698.5 Million Rupees
M impact | EQUITY | Nov 03, 2026, 02:35 PM UTC
Apple shares fall after Ternus warns of memory costs
Apple shares fell after Ternus warned about memory costs.
L impact | EQUITY | Nov 03, 2026, 02:34 PM UTC
Clorox Shares Rise About 6% After Q1 Results Beat
M impact | EQUITY | Nov 03, 2026, 02:34 PM UTC
TransAlta shares rise 7.7% as net earnings turn positive
M impact | EQUITY | Nov 03, 2026, 02:34 PM UTC
IPG Photonics Reports Third-Quarter 2026 Revenue of $287.5 Million
Revenue rose 15% year over year and exceeded FactSet estimates of $283.3 million. Adjusted EPS was $0.61 versus consensus of $0.49. IPG guided to fourth-quarter revenue of $265 mil
M impact | EQUITY | Nov 03, 2026, 02:34 PM UTC
DigitalOcean Reports Q3 Revenue of $321 Million, Raises 2026 Outlook
Third-quarter revenue rose 40% year over year to $321 million; adjusted EPS was $0.45 versus FactSet consensus of $0.32. The company guided fourth-quarter revenue to $348 million–$
M impact | EQUITY | Nov 03, 2026, 02:34 PM UTC